Hydroxychloroquine administrated at a loading dose of 1200 mg daily for three days followed by a maintenance dose of 800 mg daily (total treatment duration: two or three weeks for patients with mild to moderate or severe disease, respectively).
#Trial of iron cad plus
Multicentre, open label, randomised controlled trial.ġ6 government designated covid-19 treatment centres in China, 11 to 29 February 2020.ġ50 patients admitted to hospital with laboratory confirmed covid-19 were included in the intention to treat analysis (75 patients assigned to hydroxychloroquine plus standard of care, 75 to standard of care alone). 22 Department of Infectious Disease, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19).22 Department of Infectious Disease, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China PMC article.21 Shanghai National Research Centre for Endocrine and Metabolic Diseases, State Key Laboratory of Medical Genomics, Shanghai Institute for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.20 Clinical Research Centre, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.19 Department of Respiratory Medicine, Xiao Gan First People's Hospital, Xiaogan, Hubei Province, China.17 Departments of Respiratory Medicine, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, Hubei, China 18 Department of Respiratory Medicine, The Third People's Hospital of Yichang, Yichang, Hubei, China.16 Department of Infectious Disease, Wuhan No 7 Hospital, Wuhan, Hubei, China.15 Department of Infectious Disease, The Sixth People's Hospital of Zhengzhou, Zhengzhou, Henan, China.14 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.13 Department of Respiratory Medicine, Hubei Space Hospital of Xiaogan, Xiaogan, Hubei, China.12 Department of Respiratory Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.11 Department of Emergency Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.10 Department of Infectious Diseases, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, Hubei, China.9 Department of Respiratory Medicine, First People's Hospital of Jingzhou City, Jingzhou, Hubei, China.8 Department of Cardiovascular Medicine, Yunmeng People's Hospital, Xiaogan, Hubei, China.7 Department of Infectious Diseases, Central Hospital of Ezhou, Ezhou, Hubei, China.
4 Department of Respiratory Medicine, No 2 People's Hospital of Fuyang City, Fuyang, Anhui, China.3 Department of Infectious Disease, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.2 Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.1 Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.